Literature DB >> 6803905

Influence of contraceptive pill and menstrual cycle on serum lipids and high-density lipoprotein cholesterol concentrations.

P N Demacker, R W Schade, A F Stalenhoef, P M Stuyt, A van't Laar.   

Abstract

The fluctuations of serum lipid and lipoprotein concentrations within one cycle were studied both in women using and not using oral contraceptives. High-density lipoprotein cholesterol decreased significantly from 1.47 mmol/l (57 mg/100 ml) to 1.30 mmol/l (50 mg/100 ml) during one contraceptive cycle in eight women and rose again to the initial value during the pill-free days. The mean concentration of total cholesterol also fell significantly as a result of the decrease of high-density lipoprotein cholesterol and of a not significant decrease of low-density lipoprotein cholesterol. The mean serum triglyceride concentration did not change significantly. The fluctuations in the concentration of serum lipids and lipoproteins in 10 women not using oral contraceptives were smaller than in the women using oral contraceptives and no significant changes in the concentrations were found during one cycle. Thus, high-density lipoprotein cholesterol concentration decreases during each contraceptive cycle. The time of blood sampling during the cycle is, therefore, of vital importance in interpreting the effect of oral contraceptives on high-density lipoprotein cholesterol. In women not using oral contraceptives blood can be sampled on random days during the cycle.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6803905      PMCID: PMC1498071          DOI: 10.1136/bmj.284.6324.1213

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  19 in total

1.  Oral contraceptive use and fasting triglyceride, plasma cholesterol and HDL cholesterol.

Authors:  C H Hennekens; D A Evans; W P Castelli; J O Taylor; B Rosner; E H Kass
Journal:  Circulation       Date:  1979-09       Impact factor: 29.690

2.  Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men.

Authors:  G G Rhoads; C L Gulbrandsen; A Kagan
Journal:  N Engl J Med       Date:  1976-02-05       Impact factor: 91.245

3.  Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins.

Authors:  D D Bradley; J Wingerd; D B Petitti; R M Krauss; S Ramcharan
Journal:  N Engl J Med       Date:  1978-07-06       Impact factor: 91.245

4.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

5.  H.D.L. cholesterol during oral contraception.

Authors:  R W Schade; J P Meuwese; A J Thoben; P N Demacker
Journal:  Lancet       Date:  1978-07-01       Impact factor: 79.321

6.  Increased platelet aggregation and decreased high-density lipoprotein cholesterol in women on oral contraceptives.

Authors:  M L Bierenbaum; A I Fleischman; A Stier; P Watson; H Somol; A M Naso; M Binder
Journal:  Am J Obstet Gynecol       Date:  1979-07-15       Impact factor: 8.661

7.  Changes in lipoprotein composition during the menstrual cycle.

Authors:  H J Kim; R K Kalkhoff
Journal:  Metabolism       Date:  1979-06       Impact factor: 8.694

8.  Changes in serum high density lipoproteins in women on oral contraceptive drugs.

Authors:  R M Krauss; F T Lindgren; A Silvers; R Jutagir; D D Bradley
Journal:  Clin Chim Acta       Date:  1977-11-01       Impact factor: 3.786

9.  Cardiovascular-disease mortality trends and oral-contraceptive use in young women.

Authors:  V Beral
Journal:  Lancet       Date:  1976-11-13       Impact factor: 79.321

10.  Reduced high-density lipoprotein in women aged 40-41 using oral contraceptives. Consultation Bureau Heart Project.

Authors:  A C Arntzenius; C M van Gent; H van der Voort; C I Stegerhoek; K Styblo
Journal:  Lancet       Date:  1978-06-10       Impact factor: 79.321

View more
  1 in total

1.  Inflammatory, lipid, and body composition responses to interval training or moderate aerobic training.

Authors:  David J Elmer; Richard H Laird; Matthew D Barberio; David D Pascoe
Journal:  Eur J Appl Physiol       Date:  2015-12-31       Impact factor: 3.078

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.